Analystreport

RXi Pharmaceuticals Corp (NASDAQ: RXII) had its "buy" rating re-affirmed by analysts at HC Wainwright.

RXI PHARMACEUTICALS CORP  (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com